(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DERMAGO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

DERMAGO

ST13

US500000090542003

Class

44

Filing

90542003

Registration

7602923

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

12/17/2024

Trademark type

Word

Nice classes

44

Filing date

02/23/2021

Registration date

12/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

12/17/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Montréal, Quebec, CA

Examiner

GALLOWAY, JAMILLA ESPY

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

DermaGO Inc.

Representatives

Sean F. Mellino McDonald Hopkins LLC

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Provision of a virtual medical clinicprovision of an online service where patients can have remotely conducted visual examinationsmedical diagnoses and medical questions answered by an accredited health care professional over an online computer network

Publications

History of USPTO decisions and trademark events.

36 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2024

PUBO

PUBLISHED FOR OPPOSITION

10/15/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/10/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/09/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/09/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/09/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

05/28/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

05/28/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/21/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/21/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/21/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

03/13/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

03/13/2024

CNSI

SUSPENSION INQUIRY WRITTEN

03/13/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/12/2023

GNSL

LETTER OF SUSPENSION E-MAILED

09/12/2023

CNSL

SUSPENSION LETTER WRITTEN

09/12/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/15/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/15/2023

ALIE

ASSIGNED TO LIE

08/15/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/04/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/18/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/18/2022

CNSI

SUSPENSION INQUIRY WRITTEN

10/18/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/05/2022

GNSL

LETTER OF SUSPENSION E-MAILED

04/05/2022

CNSL

SUSPENSION LETTER WRITTEN

04/05/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/17/2021

GNSL

LETTER OF SUSPENSION E-MAILED

09/17/2021

CNSL

SUSPENSION LETTER WRITTEN

09/17/2021

DOCK

ASSIGNED TO EXAMINER

09/16/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/24/2021

NWAP

NEW APPLICATION ENTERED

02/26/2021

Continuous trademark protection

Get notified about every new filing that threatens DERMAGO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.